Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimmy Limdi

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
BMC Gastroenterology|December 5, 2021
The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in EuropeLeonardo Ruiz-Casas, Jonathan Evans, Alison Rose, et al.
Frontline Gastroenterology|June 27, 2020
Practice pattern variability in the management of acute severe colitis: a UK provider surveyShaji Sebastian, Jessica Lisle, Sreedhar Subramanian, et al.
Frontline Gastroenterology|April 29, 2021
IBD in pregnancy: recent advances, practical managementChristian P Selinger, Catherine Nelson-Piercy, Aileen Fraser, et al.
Frontline Gastroenterology|April 29, 2021
Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine SocietyChristian Selinger, Nicola Carey, Shelley Cassere, et al.
United European Gastroenterology Journal|May 9, 2026
Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative ColitisAilsa Hart, Seyedehsan Navabi, Geert D'Haens, et al.
BMJ Open Gastroenterology|March 23, 2021
Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBDChristian Philipp Selinger, Aileen Fraser, Paul Collins, et al.
BMJ Open Gastroenterology|February 10, 2023
BSG 2024 IBD guidelines protocol (standard operating procedures)Ana-Maria Darie, Vasiliki Sinopoulou, Verma Ajay, et al.
BMJ Open|November 24, 2025
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort studyAna Lilia Serna-Valverde, Eva Rodriguez-Suarez, Daniel J B Marks, et al.
Drugs in Context|February 7, 2025
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centresDavid Young, Sohail Rahmany, Deborah Taylor, et al.
Inflammatory Bowel Diseases|August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United KingdomSamuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
BMC Gastroenterology|December 5, 2021
The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in EuropeLeonardo Ruiz-Casas, Jonathan Evans, Alison Rose, et al.
Frontline Gastroenterology|June 27, 2020
Practice pattern variability in the management of acute severe colitis: a UK provider surveyShaji Sebastian, Jessica Lisle, Sreedhar Subramanian, et al.
Frontline Gastroenterology|April 29, 2021
IBD in pregnancy: recent advances, practical managementChristian P Selinger, Catherine Nelson-Piercy, Aileen Fraser, et al.
Frontline Gastroenterology|April 29, 2021
Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine SocietyChristian Selinger, Nicola Carey, Shelley Cassere, et al.
United European Gastroenterology Journal|May 9, 2026
Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative ColitisAilsa Hart, Seyedehsan Navabi, Geert D'Haens, et al.
BMJ Open Gastroenterology|March 23, 2021
Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBDChristian Philipp Selinger, Aileen Fraser, Paul Collins, et al.
BMJ Open Gastroenterology|February 10, 2023
BSG 2024 IBD guidelines protocol (standard operating procedures)Ana-Maria Darie, Vasiliki Sinopoulou, Verma Ajay, et al.
BMJ Open|November 24, 2025
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort studyAna Lilia Serna-Valverde, Eva Rodriguez-Suarez, Daniel J B Marks, et al.
Drugs in Context|February 7, 2025
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centresDavid Young, Sohail Rahmany, Deborah Taylor, et al.
Inflammatory Bowel Diseases|August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United KingdomSamuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Pageof 3